ISCA, CHRYSTEL
 Distribuzione geografica
Continente #
NA - Nord America 1.555
EU - Europa 1.206
AS - Asia 294
AF - Africa 19
OC - Oceania 7
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.092
Nazione #
US - Stati Uniti d'America 1.543
IT - Italia 469
IE - Irlanda 265
SE - Svezia 126
GB - Regno Unito 119
CN - Cina 82
DE - Germania 76
HK - Hong Kong 61
FR - Francia 39
IN - India 32
FI - Finlandia 31
TR - Turchia 22
BG - Bulgaria 20
TW - Taiwan 20
EG - Egitto 18
VN - Vietnam 15
IQ - Iraq 14
BE - Belgio 13
JP - Giappone 12
MY - Malesia 12
UA - Ucraina 12
CA - Canada 11
AU - Australia 7
KR - Corea 6
SG - Singapore 5
ES - Italia 4
EU - Europa 4
NL - Olanda 4
PK - Pakistan 4
PL - Polonia 4
AT - Austria 3
BR - Brasile 3
CZ - Repubblica Ceca 3
RO - Romania 3
RU - Federazione Russa 3
CL - Cile 2
GR - Grecia 2
IR - Iran 2
IS - Islanda 2
NO - Norvegia 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CH - Svizzera 1
ET - Etiopia 1
HR - Croazia 1
MX - Messico 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
Totale 3.092
Città #
Chandler 270
Dublin 262
Fairfield 185
Ashburn 134
Nyköping 101
Southend 79
Woodbridge 73
Houston 71
Ann Arbor 65
Seattle 64
Hong Kong 60
Wilmington 57
Cambridge 53
Dearborn 43
New York 41
Modena 33
Helsinki 31
Beijing 29
Fremont 28
Bologna 27
Redwood City 27
San Diego 25
Milan 23
Princeton 22
Sofia 20
Asyut 18
Bremen 17
Rome 17
San Giuliano Milanese 16
Shanghai 15
Baghdad 14
Banqiao 14
Dong Ket 14
Jacksonville 13
Eugene 12
Parma 11
Des Moines 10
Falls Church 10
Izmir 10
Brussels 9
Castelvetrano 9
Absecon 8
London 8
Sassuolo 8
Paris 7
Santorso 7
Genoa 6
Palermo 6
Tokyo 6
Venezia 6
Vicenza 6
Boardman 5
Bomporto 5
Carpi 5
Changchun 5
Longiano 5
Los Angeles 5
Mykolayiv 5
Savona 5
Sydney 5
Toronto 5
Amsterdam 4
Lüleburgaz 4
Marseille 4
Mesagne 4
Norwalk 4
Reggio Emilia 4
San Marco 4
Sant'Ilario d'Enza 4
Breganze 3
Brooklyn 3
Chicago 3
Chiswick 3
Coral Springs 3
Frankfurt am Main 3
Grafing 3
Guangzhou 3
Gunzenhausen 3
Hangzhou 3
Hyderabad 3
Istanbul 3
Maruggio 3
North Wales 3
Padova 3
Presezzo 3
Saludecio 3
Scandiano 3
Sint-pieters-leeuw 3
Taipei 3
Voghera 3
Washington 3
Aglientu 2
Akureyri 2
Ankara 2
Athens 2
Bagnacavallo 2
Bagnara di Romagna 2
Bangalore 2
Brembate di Sopra 2
Castel Giorgio 2
Totale 2.266
Nome #
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. 355
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? 237
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 212
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 195
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 176
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 163
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis 144
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 140
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 140
Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial 138
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 121
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 119
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 117
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 116
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 109
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 104
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 100
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 99
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. 87
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 87
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. 58
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: A single institutional retrospective report 53
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 42
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 18
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affectclinical outcome of metastatic breast cancer patients 14
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 7
Totale 3.151
Categoria #
all - tutte 11.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201972 0 0 0 0 0 0 0 0 0 24 23 25
2019/2020376 17 22 13 45 43 68 55 27 29 16 22 19
2020/2021546 45 59 24 65 72 39 15 44 43 53 13 74
2021/2022551 57 42 33 29 22 51 22 25 50 56 98 66
2022/20231.019 83 126 64 85 81 82 16 71 316 29 33 33
2023/2024499 28 26 52 66 59 75 78 58 33 24 0 0
Totale 3.151